The loss of Arena Pharmaceuticals under GAAP for 6 months of 2020 amounted to $185.135 million, compared to a profit of $558.731 million in the previous year. Revenues decreased many times to $0.262 million compared to $802.079 million a year earlier.
The loss of Arena Pharmaceuticals under GAAP for 6 months of 2020 amounted to $185.135 million, compared to a profit of $558.731 million in the previous year. Revenues decreased many times to $0.262 million compared to $802.079 million a year earlier. 
invest.arenapharm.com
English (US) 